Compulsory License season now.
Indian companies started exploring CL as an option to market drugs which are patented in India. (Whichever product patents granted on 2007-2008, are subject of CL now)
| Product/Innovator | Indian Patent No | Date of Grant | Applied by |
| Maraviroc/Pfizer | 204132 (885/MUM/1999) | 28/03/2007 | Natco |
| Sorafenib/ Bayer | 215758 (IN/PCT/2001/799/MUM) | 28/03/2008 | Natco is awardedCL for sorafenib |
| Raltegravir/Merck | 212400 (868/CHENP/2004) | 15/02/2008 | Cipla |
This list will be updated, as and when there is some news available.
